The 2025 Medicare Advantage bid cycle has been one of the most tumultuous yet, as stakeholders took a stab at addressing significant changes to the risk models, the Inflation Reduction Act, significant Star Rating changes, bid resubmissions, unexpected PDP demonstrations, and potential regulatory uncertainty from the Supreme Court. Join us for an insightful discussion as we delve into these critical topics and more. Don't miss this opportunity to stay ahead of the curve and gain valuable insights.
